284 related articles for article (PubMed ID: 29526369)
1. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.
Mathoulin-Pélissier S; Pritchard-Jones K
Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
4. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of rare cancers and inequalities in oncologic outcomes.
Gatta G; Trama A; Capocaccia R;
Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
[TBL] [Abstract][Full Text] [Related]
6. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
7. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
8. [European Reference Networks : Consequences for healthcare in Germany].
Graessner H; Schäfer F; Scarpa M; Wagner TOF
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
[TBL] [Abstract][Full Text] [Related]
9. The value of research collaborations and consortia in rare cancers.
Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
[TBL] [Abstract][Full Text] [Related]
10. [European Reference Networks for rare diseases].
Vos JR; van Zelst-Stams WAG; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2018; 162():D2376. PubMed ID: 29676715
[TBL] [Abstract][Full Text] [Related]
11. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Ray-Coquard I; Trama A; Seckl MJ; Fotopoulou C; Pautier P; Pignata S; Kristensen G; Mangili G; Falconer H; Massuger L; Sehouli J; Pujade-Lauraine E; Lorusso D; Amant F; Rokkones E; Vergote I; Ledermann JA;
Eur J Surg Oncol; 2019 Jan; 45(1):67-74. PubMed ID: 29108961
[TBL] [Abstract][Full Text] [Related]
12. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
Vos JR; Giepmans L; Röhl C; Geverink N; Hoogerbrugge N;
Fam Cancer; 2019 Apr; 18(2):281-284. PubMed ID: 30302652
[TBL] [Abstract][Full Text] [Related]
13. [Challenges for clinical research on rare tumors in Europe].
Blay JY
Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983
[TBL] [Abstract][Full Text] [Related]
14. Improving treatment results with reference centres for rare cancers: where do we stand?
Ray-Coquard I; Pujade Lauraine E; Le Cesne A; Pautier P; Vacher Lavenue MC; Trama A; Casali P; Coindre JM; Blay JY
Eur J Cancer; 2017 May; 77():90-98. PubMed ID: 28384534
[TBL] [Abstract][Full Text] [Related]
15. [Rare tumours: a new heading in Bulletin du cancer].
Massard C; Droz JP
Bull Cancer; 2010 Sep; 97(9):1031-9. PubMed ID: 20813656
[TBL] [Abstract][Full Text] [Related]
16. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER.
Rubinstein YR; Posada de la Paz M; Mora M
Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
[TBL] [Abstract][Full Text] [Related]
18. Networking in rare cancers: What was done, what's next.
Frezza AM; Trama A; Blay JY; Casali PG
Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
[TBL] [Abstract][Full Text] [Related]
19. CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer Research.
Kee D; Parker C; Bae S; Tucker KM; Harrison M; Tohidi-Esfahani I; Black M; Delahunty R; Ananda S; Friedlander M; Cunliffe HE; Gibbs P; Desai J; Trotman J; Scott CL
JCO Clin Cancer Inform; 2020 Feb; 4():136-146. PubMed ID: 32083956
[TBL] [Abstract][Full Text] [Related]
20. [Healthcare networks for people with rare diseases: integrating data and expertise].
Graessner H; Storf H; Schaefer F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
